Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazunori Uenaka
Observed names:
K. Uenaka,
Kazunori UENAKA,
植仲和典
Institution:
Eli Lilly (Japan)
Observed institutions:
Otsuka (Japan),
Kyushu University,
Eli Lilly (Japan)
OpenAlex ID:
A5011080430
Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
2010
·
M. Tanioka
, H. Nokihara
, et al.
·
Cancer Chemotherapy and Pharmacology
·
87
Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus
2008
·
Prajakti A. Kothare
, Helle Linnebjerg
, et al.
·
The Journal of Clinical Pharmacology
·
64
Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of the Amyloid β Monoclonal Antibody Solanezumab in Japanese and White Patients With Mild to Moderate Alzheimer Disease
2011
·
Kazunori Uenaka
, Masako Nakano
, et al.
·
Clinical Neuropharmacology
·
44
Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors
2015
·
Toshihiko Doi
, Takayuki Yoshino
, et al.
·
Anti-Cancer Drugs
·
37
A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer
2017
·
Daisuke Sakai
, Hyun Cheol Chung
, et al.
·
Cancer Chemotherapy and Pharmacology
·
32
PDF
Effects of teriparatide in Japanese and non-Japanese populations: bridging findings on pharmacokinetics and efficacy
2011
·
Mika Tsujimoto
, Kazunori Uenaka
, et al.
·
Journal of Bone and Mineral Metabolism
·
22
Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors
2013
·
Noboru Yamamoto
, Hiroshi Nokihara
, et al.
·
Cancer Chemotherapy and Pharmacology
·
19
CPT‐11: Population Pharmacokinetic Model and Estimation of Pharmacokinetics Using the Bayesian Method in Patients with Lung Cancer
1994
·
Nobuyuki Yamamoto
, Tomohide Tamura
, et al.
·
Japanese Journal of Cancer Research
·
18
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies
2016
·
Kiyotaka Yoh
, Toshihiko Doi
, et al.
·
Investigational New Drugs
·
13
PDF
Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma
2016
·
Shinsuke Iida
, Daisuke Ogiya
, et al.
·
Cancer Science
·
12
PDF
P1‐448: Solanezumab was safe and well‐tolerated for Asian patients with mild‐to‐moderate Alzheimer's disease in a multicenter, randomized, open‐label, multi‐dose study
2010
·
Taro Goto
, Shinji Fujikoshi
, et al.
·
Alzheimer s & Dementia
·
7
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Galcanezumab, a Monoclonal Antibody to Calcitonin Gene-Related Peptide, in Healthy Japanese and Caucasian Subjects
2017
·
Masako NAKANO
, Kazunori UENAKA
, et al.
·
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
·
5
PDF
Population Pharmacokinetic Analysis of Mexiletine in Adult Arrhythmic Patients in Japanese Population.
1998
·
Kazunori UENAKA
, Toshiko KOUE
, et al.
·
Biological and Pharmaceutical Bulletin
·
5
PDF
Radiation dosimetry and pharmacokinetics of florbetapir (18F) in Japanese subjects
2019
·
Masako Nakano
, Tomomi Nakamura
, et al.
·
Annals of Nuclear Medicine
·
3
Abstract B48: A phase 1 study of an antisense oligonucleotide against survivin (LY2181308) in Japanese patients with solid tumors
2009
·
Hiroshi Nokihara
, Noboru Yamamoto
, et al.
·
Molecular Cancer Therapeutics
·
3
P4‐379: Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple‐dose administration of a gamma‐secretase inhibitor in Japanese subjects
2008
·
Miki Kumamoto
, Masako Nakano
, et al.
·
Alzheimer s & Dementia
·
2
Pharmacological, pharmacokinetic, and clinical profile of tadalafil (Cialis®)
2008
·
Takafumi Yamaguchi
, Kazunori Uenaka
, et al.
·
Folia Pharmacologica Japonica
·
2
PDF
[Combined determination of urine uracil levels and plasma 5-FU clearance for a simple order-made treatment with anticancer agents of FU derivative].
2003
·
Shigehumi Morimoto
, Hideyuki Mishima
, et al.
·
PubMed
·
2
Abstract C121: A non-randomized, open-label, single-arm, phase 2 study of LY2875358 in Asian patients with MET diagnostic positive, advanced gastric cancer
2015
·
Hyun Cheol Chung
, Taroh Satoh
, et al.
·
Molecular Cancer Therapeutics
·
1
Population pharmacokinetics of duloxetine in Japanese pediatric patients with major depressive disorder
2023
·
Risa Yokokawa Shibata
, Ryuji Kubota
, et al.
·
Drug Metabolism and Pharmacokinetics
ヒト化抗アミロイドβモノクローナル抗体LY2062430をアルツハイマー型認知症を有する日本人に単回投与したときの安全性,薬物動態並びに血漿中Aβ1‐40及びAβ1‐42濃度変化
2009
·
植仲和典
, 後藤太郎
, et al.
Development of Therapeutic Drug Monitoring Software Using Parameters of Japanese Population.
2002
·
Youichi Hiraki
, Kazunori Uenaka
, et al.
·
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
PDF
Show more works
View as search
Works count:
22
Citation count:
378
H-index:
10
I10-index:
10
Year
Topic
Type